Skip to content

DexCom Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 29, 2026 results vs estimates

DexCom Inc · E.DXCM.NASDAQ · United States
Use symbol E.DXCM.NASDAQ in our API & Excel add-in to retrieve this data ↓
79.93
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 0%
Bubble Risk LOW
Realised Volatility (20D) 37.93%

DexCom Inc Forecast

DexCom Inc short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 37.9% a year, a typical one-standard-deviation range is 75.66–84.20 over a week, 71.18–88.68 over a month and 49.61–110.25 over a year. (Signals as of 1 Nov 2026.)

DexCom Inc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
DexCom Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
DexCom Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
DexCom Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
DexCom Inc
P/E
30.93x
Cheap vs own history
QoQ −14.5%
YoY −9.2%
now 30.931525.64 low41.29 high
ⓘP/E As of 22 Nov 2026.See DexCom Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
DexCom Inc
P/S
6.01x
Cheap vs own history
QoQ −17.5%
YoY +10.5%
now 6.00524.95 low7.28 high
ⓘP/S As of 22 Nov 2026.See DexCom Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
DexCom Inc
P/B
12.09x
Mid-range vs own history
QoQ −12.4%
YoY +34.3%
now 12.09018.07 low13.8 high
ⓘP/B As of 22 Nov 2026.See DexCom Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
DexCom Inc
EV/EBITDA
19.49x
Cheap vs own history
QoQ −14.7%
YoY +0.2%
now 19.49215.43 low23.73 high
ⓘEV/EBITDA As of 22 Nov 2026.See DexCom Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
DexCom Inc
EV/Sales
5.92x
Cheap vs own history
QoQ −17.4%
YoY +12.4%
now 5.9224.74 low7.17 high
ⓘEV/Sales As of 22 Nov 2026.See DexCom Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
DexCom Inc
FCF Yield
3.6%
Mid-range vs own history
QoQ −7.7%
YoY −17.2%
now 3.5833.44 low5.99 high
ⓘFCF Yield As of 22 Nov 2026.See DexCom Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
DexCom Inc
Earnings Yield
3.2%
Strong vs own history
QoQ +17.0%
YoY +10.1%
now 3.23292.42 low3.9 high
ⓘEarnings Yield As of 22 Nov 2026.See DexCom Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
DexCom Inc
Market Cap
$30.7B
Mid-range vs own history
QoQ −15.3%
YoY +24.9%
now 30653.15523,856 low36,179 high
ⓘMarket Cap As of 22 Nov 2026.See DexCom Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
DexCom Inc
Net Debt
-$425M
Mid-range vs own history
QoQ −22.5%
YoY −43.1%
now -425-1,030 low-425 high
ⓘNet Debt As of 22 Nov 2026.See DexCom Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
DexCom Inc
Net Debt / EBITDA
-0.27x
Mid-range vs own history
QoQ −22.1%
YoY −55.1%
now -0.2741-0.7 low-0.27 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See DexCom Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
DexCom Inc
Current Ratio
1.74x
Mid-range vs own history
QoQ +0.3%
YoY +11.1%
now 1.73841.56 low1.95 high
ⓘCurrent Ratio As of 22 Nov 2026.See DexCom Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
DexCom Inc
Quick Ratio
1.40x
Mid-range vs own history
QoQ −2.0%
YoY +0.9%
now 1.39631.38 low1.64 high
ⓘQuick Ratio As of 22 Nov 2026.See DexCom Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
DexCom Inc
Interest Coverage
95.21x
Strong vs own history
QoQ +10.3%
YoY +85.0%
now 95.20951.47 low95.21 high
ⓘInterest Coverage As of 22 Nov 2026.See DexCom Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
DexCom Inc
Debt / Equity
0.55x
Low vs own history
QoQ +3.0%
YoY −41.8%
now 0.54940.47 low0.94 high
ⓘDebt / Equity As of 22 Nov 2026.See DexCom Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
DexCom Inc
Piotroski F-Score
9
Strong vs own history
QoQ 0.0%
YoY +50.0%
now 96 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See DexCom Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
DexCom Inc
Altman Z-Score
7.49
Mid-range vs own history
QoQ −6.9%
YoY +55.3%
now 7.48774.99 low8.04 high
ⓘAltman Z-Score As of 22 Nov 2026.See DexCom Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for DexCom Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

DexCom Inc fundamentals: income statement, balance sheet & cash flow

DexCom Inc reported revenue of $4.66bn and net income of $836.3m in FY2025, the year ended 31 December 2025 — revenue up 15.6% and net income up 45.1% on the prior year. Free cash flow was $1.08bn. These figures are as reported in the filings, not restated: 26 fiscal years and 92 quarters of history, back to December 2000. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$4.66bn
+15.6%
Net income
$836.3m
+45.1%
Gross margin
60.10%
Free cash flow
$1.08bn
+70.8%
Net debt
$472.0m
Shares short (30 Oct 2026)
15.93m
2.81 days to cover
DexCom Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue4,662.04,033.03,622.32,909.82,448.5
Cost of revenue1,860.11,594.81,333.41,026.7768.0
Gross profit2,801.92,438.22,288.91,883.11,680.5
Research & development599.1552.4505.8484.2604.2
Selling, general & admin.1,291.0——1,007.7810.5
Operating income911.8600.0597.7391.2265.8
EBITDA1,358.5945.7916.7565.3377.6
Interest expense18.319.020.318.618.8
Pre-tax income1,088.4709.0710.4390.8256.8
Income tax252.1132.8168.949.639.9
Net income836.3576.2541.5341.2216.9

Download DexCom Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.DXCM.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 26 fiscal years and 92 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on DexCom Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

DexCom Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to DexCom Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How DexCom Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how DexCom Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About DexCom Inc (United States)

DexCom Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is DexCom Inc?
DexCom Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest DexCom Inc price?
The latest close is 79.93 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is DexCom Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is neutral (4 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is DexCom Inc?
20-day realised volatility is 37.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 10.9% over a month and 5.3% over a week.
What factors affect DexCom Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to DexCom Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade DexCom Inc?
58 backtested tactical asset allocation strategies trade DexCom Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are DexCom Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of DexCom Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free DexCom Inc historical data?
In the Free historical data section of this page: the last 10 years of DexCom Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free DexCom Inc historical data (last 10 years)

Browse or instantly download the last 10 years of DexCom Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.DXCM.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2079.32
2026-11-1980.19
2026-11-1882.52
2026-11-1782.04
2026-11-1681.61
2026-11-1383.33
2026-11-1281.39
2026-11-1180.345
2026-11-1079.92
2026-11-0981.07
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.